SEC Form 4 · accession 0000899243-17-022018
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sachiko Kuno
10% Owner
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Sep 11, 2017 | S | 1,000,000 | $12.00 | D | 7,137,344 | I | By SK Impact Fund, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 11, 2017, the reporting person sold 1,000,000 shares through a block trade pursuant to Rule 144 under the Securities Act of 1933, as amended.